Skip to main content

SHAREHOLDER ALERT: CBL HRTX CLDR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / July 12, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

CBL & Associates Properties, Inc (NYSE: CBL)
Lead Plaintiff Deadline : July 16, 2019
Class Period: July 29, 2014 to March 26, 2019

Get additional information about CBL: http://www.wongesq.com/pslra-1/cbl-associates-properties-inc-loss-submission-form?prid=2387&wire=1

Heron Therapeutics, Inc. (NASDAQ: HRTX)
Lead Plaintiff Deadline : August 5, 2019
Class Period: October 31, 2018 to April 30, 2019

Get additional information about HRTX: http://www.wongesq.com/pslra-1/heron-therapeutics-inc-loss-submission-form?prid=2387&wire=1

Cloudera, Inc. (NYSE: CLDR)
Lead Plaintiff Deadline : August 6, 2019
Class Period: April 28, 2017 to June 5, 2019

Get additional information about CLDR: http://www.wongesq.com/pslra-1/cloudera-inc-loss-submission-form?prid=2387&wire=1

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/551843/SHAREHOLDER-ALERT-CBL-HRTX-CLDR-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.